<?xml version="1.0" encoding="UTF-8"?>
<p>Obesity is a risk factor for cardiovascular disease. In different studies, melatonin has been shown to have anti-obesity effects (
 <xref rid="B30" ref-type="bibr">30</xref>, 
 <xref rid="B31" ref-type="bibr">31</xref>). Taking melatonin reduces intra-abdominal visceral fat deposition and body weight. Its antiobesogenic effects are believed to be due to two processes: regulation of energy reserves and a relationship with the physiological processes of wakefulness/sleep rhythm (
 <xref rid="B32" ref-type="bibr">32</xref>).
</p>
